Lymphoid enhancer-binding factor 1 (LEF1)

Lymphoid enhancer-binding factor 1 (LEF1) is a DNA-binding transcription factor that is a key downstream mediator of the Wnt/β-catenin signaling pathway, regulating the expression of genes involved in cell proliferation, differentiation, and survival[1][2][3][6]. LEF1 is essential for the maximal activation of the T-cell receptor-alpha enhancer, contributing to T-cell development and differentiation, and plays broader roles in the regulation of hair follicle morphogenesis and odontogenesis[1][2]. It is implicated in the pathogenesis of various cancers, developmental syndromes, and immune cell maturation, with mutations or altered expression correlating with disease states[1][3][6].

Other names

LEF-1TCF1-alphaTCF1ALPHATCF10TCF7L3T cell-specific transcription factor 1-alphaECTD1ECTD17

Drugs targeting LEF1 (if any) would likely act as modulators or inhibitors of transcriptional activity or the Wnt signaling pathway.